Results for: Pharmaceutical Partnership

Harvest Integrated Research Organization (HiRO) and CHA University Bundang Medical Center (CBMC) formed a strategic partnership to enhance clinical trial capabilities in South Korea. The collaboration will leverage both organizations’ expertise to provide comprehensive solutions for global pharmaceutical and biotech companies. This partnership aims to accelerate medical breakthroughs and improve patient outcomes by streamlining clinical trial processes and showcasing South Korea’s research excellence on a global scale.

NeuroSense Therapeutics is in advanced discussions with major pharmaceutical companies for a potential partnership to develop and commercialize its ALS drug candidate, PrimeC. The company anticipates receiving terms for the partnership in the fourth quarter of 2024, based on promising Phase 2b trial data showing PrimeC’s efficacy in mitigating ALS progression and improving survival rates.